Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Lyu, Yunxiao* | Cheng, Yunxiao | Wang, Bin | Chen, Liang | Zhao, Sicong
Affiliations: Department of General Surgery, Dongyang People’s Hospital, Dongyang, Zhejiang, China
Correspondence: [*] Corresponding author: Yunxiao Lyu, Department of General Surgery, Dongyang People’s Hospital, No. 60, West Wuning Road, 322100 Dongyang, Zhejiang, China. Tel./Fax: +86 579 86856081; E-mail: lvyunxiao1986@gmail.com.
Abstract: BACKGROUND: Recent studies have shown that Sulfatase 1 (SULF1) plays a crucial role in the genesis, development, and progression of tumors. However, there have been few studies on the role of SULF1 in pancreatic cancer. OBJECTIVE: The present study examined the differences in SULF1 expression levels between pancreatic cancer and normal tissues, and their correlation with the clinicopathological features and prognosis. METHODS: A total of 65 pancreatic cancer samples were enrolled in this study. An immunohistochemical assay were used in this study. The relationship between SULF1 expression and clinicopathological features were tested using χ2 test or Fisher’s exact test. The Kaplan-Meier method was used to calculate the cumulative survival rates of the patients. RESULTS: The study showed that the SULF1 expression level was higher in pancreatic cancer tissues than in normal tissues. Analysis of the clinical and pathological data of patients revealed that high SULF1 expression was associated with later T, N, and TNM stages, higher CA19-9 levels, smaller tumor size, and poorer prognosis. CONCLUSIONS:These findings suggested that SULF1 could be an indicator of the clinicopathological features and prognosis of pancreatic cancer.
Keywords: Sulfatase 1, pancreatic cancer, metastasis, prognosis
DOI: 10.3233/CBM-181210
Journal: Cancer Biomarkers, vol. 22, no. 4, pp. 701-707, 2018
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl